Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021005
Company: FOUGERA PHARMS
Company: FOUGERA PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SOLARAZE | DICLOFENAC SODIUM | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL;TOPICAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/16/2000 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21005ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21005_Solaraze.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
11/21/2024 | SUPPL-25 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021005s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021005Orig1s025ltr.pdf | |
11/14/2022 | SUPPL-24 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021005Orig1s024ltr.pdf | |
04/05/2022 | SUPPL-23 | Labeling-Package Insert |
Label (PDF)
Label (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005Orig1s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s023lbl.pdf#page=21 | |
04/28/2021 | SUPPL-22 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021005s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021005Orig1s022ltr.pdf | |
05/16/2016 | SUPPL-17 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/09/2016 | SUPPL-16 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021005s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021005Orig1s016ltr.pdf | |
03/30/2015 | SUPPL-15 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/08/2011 | SUPPL-13 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021005s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021005s013ltr.pdf | |
06/01/2007 | SUPPL-10 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021005s010ltr.pdf |
07/23/2004 | SUPPL-9 | Manufacturing (CMC)-Packaging |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21005s009ltr.pdf |
03/18/2004 | SUPPL-7 | Manufacturing (CMC)-Control |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21005scs007ltr.pdf |
04/29/2003 | SUPPL-6 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21005slr006_solaraze_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21005slr006ltr.pdf | |
12/13/2002 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/20/2002 | SUPPL-4 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
02/19/2002 | SUPPL-3 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
10/02/2001 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
08/17/2001 | SUPPL-1 | Labeling |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
11/21/2024 | SUPPL-25 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021005s025lbl.pdf | |
11/14/2022 | SUPPL-24 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf | |
04/05/2022 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005Orig1s023lbl.pdf | |
04/05/2022 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s023lbl.pdf#page=21 | |
04/28/2021 | SUPPL-22 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021005s022lbl.pdf | |
05/09/2016 | SUPPL-16 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021005s016lbl.pdf | |
05/09/2016 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021005s016lbl.pdf | |
12/08/2011 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021005s013lbl.pdf | |
04/29/2003 | SUPPL-6 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21005slr006_solaraze_lbl.pdf | |
10/16/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21005lbl.pdf |